ARBB Arbuthnot Banking Group

Hardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’

Hardman & Co Research
Hardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’

13-Nov-2023 / 15:40 GMT/BST
The issuer is solely responsible for the content of this announcement.


Hardman & Co analyst interview | Banks

Q&A on Arbuthnot Banking Group (ARBB) | Strategic progress and investments towards ‘Future State 2’
 

Arbuthnot Banking Group (LON:ARBB) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews.

In this interview, Mark talks about how Arbuthnot Banking Group is progressing strategically towards its “Future State 2” plan and covers a few key areas including the growth of specialist SME finance divisions, the optimisation of the core relationship banking franchise, and the significant investments aimed at propelling the business forward. Mark also discusses ABG’s impressive deposit growth, the robust performance of their credit book amidst a challenging environment, and the expansion of their central London headquarters to accommodate future demands.

Arbuthnot Banking Group is a holding company for Arbuthnot Latham & Co., it offers carefully crafted expert private and commercial banking services alongside wealth planning advice from Chartered Wealth Planners and discretionary investment management.

Listen to the interview

 

If you are interested in meeting the company, you can register your interest

To contact us:

Hardman & Co
1 Frederick's Place

London

EC2R 8AE

Follow us on Twitter @HardmanandCo

Analyst:

Mark Thomas



 

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

 



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1772095  13-Nov-2023 

fncls.ssp?fn=show_t_gif&application_id=1772095&application_name=news&site_id=research_pool
EN
13/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arbuthnot Banking Group

Mark Thomas ... (+3)
  • Mark Thomas
  • Martin Hall
  • Mike Foster

Hardman & Co Monthly: April 2026

Feature article: 2025 pharma statistics, by Dr Martin Hall, Head of Life Sciences at Hardman & Co Our pharmaceutical dataset has been compiled over 40 years from 109 companies, which, through M&A activity and consolidation, now comprise 46 companies. An efficient reporting system has seen all the listed multinational pharma companies announce results for 2025, giving us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmac...

Arbuthnot Banking Group: 1 director

A director at Arbuthnot Banking Group bought 300,000 shares at 860p and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Brian Moretta ... (+3)
  • Brian Moretta
  • Mark Thomas
  • Mike Foster

Hardman & Co Monthly: March 2026

Feature article: Tech sector outlook | Small cap finding support at COVID-19 levels The past year has been a challenging period for UK technology stocks. The sector has diverged from buoyant UK blue chips due to the perceived threats of AI-induced disruption. This underperformance has been regardless of generally positive trading news, and larger cap software & services companies have performed significantly worse than their smaller brethren. Takeovers have continued to pick off the remainin...

Mark Thomas ... (+3)
  • Mark Thomas
  • Mike Foster
  • Nigel Hawkins

The Monthly: February 2026

Stormy times at present – a sunnier outlook? Undoubtedly, 2025 was a difficult year for Infrastructure Investment Companies (IICs) and Renewable Energy Infrastructure Funds (REIFs). Investors have seen underperformance against the FTSE 100, widening NAV discounts, several delistings, managed wind-downs (MWDs) and regulatory issues both in the UK and in the US. The question for investors is: where do we go from here? On the one hand, yields for some REIFS are well over twice those of 10-year gil...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch